Clinical Trial Update: Renal Outcomes in the Early Use of Vasopressin in the Treatment of Septic Shock [Phase 4]

View source ↗

Summary

A Phase 4 study is evaluating the renal outcomes of early vasopressin use in treating septic shock, with enrollment currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Septic Shock

Drugs mentioned

• VASOPRESSIN (VASOPRESSIN)

Snippet

Sponsor: Azienda Usl di Bologna | Conditions: Septic Shock, Renal Function Replacement | Phase 4 | Status: RECRUITING